Shares of Merck and Pfizer are way down from their previous peaks. Merck's lead drug, Keytruda, grew sales by 19% last year, but its era of patent-protected exclusivity is approaching its end.

In October, Merck took up an option on the personalised RNA-based cancer vaccine with an upfront payment of $250 million as part of a collaboration first agreed in 2016 and expanded in 2018.

During an R&D update yesterday Merck said it is hoping to claim eight new cardiovascular therapy approvals between now and 2030, for diseases like atherosclerosis, heart failure, pulmonary ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

two cups of coffee being poured - Stefania Pelfini, La Waziya Photography/Getty Images ...

There is no Morningstar’s Analysis data available. We sell different types of products and services to both investment professionals and individual investors. These products and services are ...

Remember a time when the only way to get a proper coffee fix was to head to your favourite local coffee shop or cafe? Now, thankfully, the world of high grade specialty coffee is no longer gate ...

Coffee is one of the world’s most cherished beverages, yet not many know it has a history that extends beyond its traditional role as a drink. While commonly associated with morning routines and sweet ...